Table 1.
Baseline characteristics
| N (%) | ||
|---|---|---|
| Age years | 72 (51–86) | |
| Gender | F14 (32) M29 (68) | |
| Follow-up months | 8 (1–37) | |
| STAGE | Rai I/II | 23 (53) |
| Rai III/IV | 20 (47) | |
| Binet A/B | 26 (60) | |
| Binet C | 17 (40) | |
| FISH | del13 | 13 (30) |
| trisomy 12 | 3 (7) | |
| del17p or TP53 mut | 12 (28) | |
| del11q | 5 (12) | |
| VHIG | Mutated | 10/36 (28) |
| Unmutated | 26/36 (72) | |
| Treatment | First-line | 12 (28) |
| ≥Second line | 31 (72) | |
| Cardiovascular comorbidities | Previous AF | 5 (12) |
| AH | 23 (53) | |
| Valvular heart disease | 20 (47) | |
| CAD | 8 (19) | |
| PAD | 4 (9) | |
| Diabetes | 4 (9) | |
| Hypothyroidism | 5 (12) | |
| Dislipidaemia | 12 (28) | |
| Smoke | 1 (2) | |
| BMI > 25 | 7 (16) |
Values are given as median (range) or as N (%). AH arterial hypertension, CAD coronary artery disease, PAD peripheral artery disease, BMI body mass index